High level insect expression of rage proteins
OwnerRobert B. Harris, Jane M. Shen +1inventors
InventorsRobert B. Harris, Jane M. Shen, Manouchehr Shahbaz
Life of this patent
Estimating the term…
Loading patent…
OwnerRobert B. Harris, Jane M. Shen +1inventors
InventorsRobert B. Harris, Jane M. Shen, Manouchehr Shahbaz
Estimating the term…
The present invention provides a method for high level expression of human sRAGE using insect cell culture. In an embodiment, the method comprises (a) subcloning a nucleotide sequence encoding RAGE or a fragment thereof into a virus; (b) preparing a high-titer stock of recombinant virus; and (c) infecting host cells with the high-titer recombinant virus under conditions such that pre-determined levels of RAGE or a fragment thereof is produced, wherein said pre-determined levels of RAGE are at least 25 mg recombinant protein per liter of culture. The invention comprises use of sRAGE prepared by the methods of the invention for treatment of AGE-related syndromes including complications associated with atherosclerosis, diabetes, kidney failure, systemic lupus nephritis or inflammatory lupus nephritis, amyloidoses, Alzheimer's disease, cancer, inflammation, and erectile dysfunction.
A method for high level expression of recombinant forms of the Receptor for Advanced Glycated Endproducts (RAGE) or fragments thereof comprising:
A method for high level expression of recombinant human Receptor for Advanced Glycated Endproducts (RAGE) comprising:
A method for high level expression of recombinant human Receptor for Advanced Glycated Endproducts (RAGE) comprising:
Dependencies are inferred from the claim text.